DevicePMAs@therightstef:P000046_S023 JSONTXT

Approval for a new trade name. the device, as modified, will be marketed under the trade name nuvisctm and is indicated for use during surgery in the anterior and posterior segments of the human eye. procedures include: cataract extraction, intraocular lens (iol) implantation, corneal transplantation surgery, glaucoma filtering surgery, and surgical procedures to reattach the retina.